Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Horizon Pharma Inc - US Operations
EIR
•Horizon Pharma Inc - US Operations•June 6, 2017

Horizon Pharma Inc - US Operations – FDA EIR, Jun 6, 2017

Record Details

An FDA inspection of Horizon Pharma Inc.'s Lake Forest, IL facility was conducted from May 9 to June 6, 2017. This inspection focused on Postmarketing Adverse Drug Experience (PADE) Reporting, aligning with CDER's performance goals and Compliance Program 7353.001A for postmarketing safety reporting, ensuring adherence to 21 CFR requirements. Horizon Pharma is a specialty biopharmaceutical distributor of prescription human drug products. Significantly, no FDA-483 (Inspectional Observations) was issued, and no discussion items were communicated to company management, indicating a compliant status. The inspection confirmed that the company had successfully corrected two previous issues identified during a 2014 inspection. These earlier items involved refining the main Adverse Drug Experience (ADE) reporting procedure to include global references and clearer guidance for 15-day follow-up reports, and accurately detailing the 3-day timeframe for NDA Field Alert Reports. Although three instances of late 15-Day Alert submissions were noted, the firm provided sufficient justification through its investigations. Ultimately, no new violations or mandatory actions were identified during this inspection, affirming the company's compliance with adverse drug experience reporting regulations.

Company
Horizon Pharma Inc - US Operations
Inspection date
June 6, 2017
Product type
drugs
Office
Chicago District Office
People
  • Jeffrey W. Sherman (company_representative)
  • Andy Hartman (company_representative)
  • Larry P. Bell (company_representative)
  • Ray Labayo (company_representative)
  • Ignacio Lopez (company_representative)
View Company Profile

ID · 3da4d7af-1239-4873-844d-095930aeb05f

Violation Codes1
21 CFR 820.198

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Horizon Pharma Inc - US Operations
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.